{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:56:16Z","timestamp":1792068976240,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,10,18]],"date-time":"2007-10-18T00:00:00Z","timestamp":1192665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s10689-007-9167-3","type":"journal-article","created":{"date-parts":[[2007,10,17]],"date-time":"2007-10-17T03:57:24Z","timestamp":1192593444000},"page":"91-95","source":"Crossref","is-referenced-by-count":22,"title":["Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist"],"prefix":"10.1007","volume":"7","author":[{"given":"Edibaldo","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,18]]},"reference":[{"key":"9167_CR1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1075-122X.2004.21543.x","volume":"10","author":"A Stolier","year":"2004","unstructured":"Stolier A, Fuhrman G et\u00a0al (2004) Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA1 or BRCA2 mutation. Breast J 10:475\u2013480","journal-title":"Breast J"},{"key":"9167_CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/gte.1997.1.85","volume":"2","author":"A Ganguly","year":"1997","unstructured":"Ganguly A, Leahy K et\u00a0al (1997) Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations. Genet Test 2:85\u201390","journal-title":"Genet Test"},{"key":"9167_CR3","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","volume":"20","author":"SR Lakhani","year":"2002","unstructured":"Lakhani SR, van de Vijver MJ et\u00a0al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers, estrogen receptor, progesterone receptor, HER-2 Neu and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20:2310\u20132318","journal-title":"J Clin Oncol"},{"key":"9167_CR4","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/cncr.11688","volume":"98","author":"WD Foulkes","year":"2003","unstructured":"Foulkes WD, Metcalfe K et\u00a0al (2003) Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer 98:1569\u20131577","journal-title":"Cancer"},{"key":"9167_CR5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1200\/JCO.2001.19.4.924","volume":"19","author":"CTM Brekelmans","year":"2001","unstructured":"Brekelmans CTM, Seynaeve C et\u00a0al (2001) Effectiveness of breast cancer surveillance in BRCA1\/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19:924\u2013930","journal-title":"J Clin Oncol"},{"key":"9167_CR6","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2002.20.5.1260","volume":"20","author":"L Scheuer","year":"2002","unstructured":"Scheuer L, Kauf N et\u00a0al (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20:1260\u20131268","journal-title":"J Clin Oncol"},{"key":"9167_CR7","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/cncr.20298","volume":"100","author":"G Schwartz","year":"2004","unstructured":"Schwartz G, Hortogyi GN (2004) Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of breast, April 26\u201328, 2003, Philadelphia, Pennsylvania. Cancer 100:2512\u20132532","journal-title":"Cancer"},{"key":"9167_CR8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/oxfordjournals.jncimonographs.a003469","volume":"30","author":"N Wolmark","year":"2001","unstructured":"Wolmark N, Wang J, Mamounas E et\u00a0al (2001) Preoperative chemotherapy in patients with operable breast cancer: nine-year results from NSABP B-18. J Natl Cancer Inst Monogr 30:96\u2013102","journal-title":"J Natl Cancer Inst Monogr"},{"key":"9167_CR9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1075-122X.2006.00261.x","volume":"12","author":"B Cady","year":"2006","unstructured":"Cady B, Chung M et\u00a0al (2006) Re: genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations. Breast J 12:282\u2013283","journal-title":"Breast J"},{"key":"9167_CR10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/sonc.2001.26150","volume":"28","author":"EP Mammounas","year":"2001","unstructured":"Mammounas EP, Fisher B (2001) Preoperative (neoadjuvant) chemotherapy in patients with breast cancer. Semin Oncol 28:389\u2013399","journal-title":"Semin Oncol"},{"key":"9167_CR11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.sembd.2005.01.002","volume":"7","author":"V Tsikitis","year":"2004","unstructured":"Tsikitis V, Chung M et\u00a0al (2004) Scientific basis of neoadjuvant therapy. Semin Breast Dis 7:51\u201357","journal-title":"Semin Breast Dis"},{"key":"9167_CR12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1524-4741.2003.09624.x","volume":"9","author":"E Warner","year":"2003","unstructured":"Warner E, Trudeau M et\u00a0al (2003) Sensitivity of BRCA1-related breast cancer to neoadjuvant chemotherapy. Practical implications. Breast J 9:507\u2013508","journal-title":"Practical implications. Breast J"},{"key":"9167_CR13","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2000.18.19.3360","volume":"18","author":"LJ Pierce","year":"2000","unstructured":"Pierce LJ, Struderman M et\u00a0al (2000) Effect of radiotherapy after breast conserving treatment in women with breast cancer and germline BRCA1\/2 mutations. J Clin Oncol 18:3360\u20133369","journal-title":"J Clin Oncol"},{"key":"9167_CR14","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(02)08434-9","volume":"359","author":"B Hafty","year":"2002","unstructured":"Hafty B, Harrold E et\u00a0al (2002) Outcome of conservatively managed early onset breast cancer by BRCA1\/2 status. Lancet 359:1471\u20131477","journal-title":"Lancet"},{"key":"9167_CR15","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/cncr.20221","volume":"100","author":"IK Komenaka","year":"2004","unstructured":"Komenaka IK, Ditkoff BA et\u00a0al (2004) The development of interval breast malignancies in patients with BRCA mutations. Cancer 100:2079\u20132083","journal-title":"Cancer"},{"key":"9167_CR16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.prs.0000201478.64877.87","volume":"117","author":"JA Ascherman","year":"2006","unstructured":"Ascherman JA, Hanasono MM et\u00a0al (2006) Implant reconstruction in breast cancer patients treated with radiation therapy. Plast Reconstr Surg 117:359\u2013365","journal-title":"Plast Reconstr Surg"},{"key":"9167_CR17","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1200\/JCO.2005.10.035","volume":"23","author":"SA Narod","year":"2005","unstructured":"Narod SA, Offit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23:1656\u20131663","journal-title":"J Clin Oncol"},{"key":"9167_CR18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","volume":"340","author":"LC Hartmann","year":"1999","unstructured":"Hartmann LC, Schaid DJ (1999) Effect of bilateral prophylactic mastectomy in women with a familial history of breast cancer. N Engl J Med 340:77\u201384","journal-title":"N Engl J Med"},{"key":"9167_CR19","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"LC Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA et\u00a0al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93:1633\u20131637","journal-title":"J Natl Cancer Inst"},{"key":"9167_CR20","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1200\/JCO.2005.08.903","volume":"23","author":"M Schwartz","year":"2005","unstructured":"Schwartz M (2005) Contralateral prophylactic mastectomy: efficacy, satisfaction, regret. J Clin Oncol 23:7777\u20137779","journal-title":"J Clin Oncol"},{"key":"9167_CR21","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"221","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T et\u00a0al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers. The PROSE Study Group. J Clin Oncol 221:1055\u20131062","journal-title":"J Clin Oncol"},{"key":"9167_CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van Geel B et\u00a0al (2001) Breast cancer after prophylactic bilateral mastectomy in women with BRCA1 or BRCA2 mutations. N Engl J Med 345:159\u2013164","journal-title":"N Engl J Med"},{"key":"9167_CR23","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","volume":"295","author":"T Walsh","year":"2006","unstructured":"Walsh T, Casadei S et\u00a0al (2006) Spectrum of mutations in BRCA1, BRCA2, chek2, and TP53 in families at high risk of breast cancer. JAMA 295:1379\u20131387","journal-title":"JAMA"},{"key":"9167_CR24","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1200\/JCO.2000.18.9.1980","volume":"18","author":"A Eisen","year":"2000","unstructured":"Eisen A, Rebbeck TR et\u00a0al (2000) Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol 18:1980\u20131995","journal-title":"J Clin Oncol"},{"key":"9167_CR25","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"TR Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT et\u00a0al (2002) Prophylactic oophorectomy in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 346:1616\u20131621","journal-title":"N Engl J Med"},{"key":"9167_CR26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/jmg.40.8.591","volume":"40","author":"P Watson","year":"2003","unstructured":"Watson P, Narod SA et\u00a0al (2003) Carrier risk status changes resulting form mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast ovarian cancer. J Med Genet 40:591\u2013596","journal-title":"J Med Genet"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-007-9167-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-007-9167-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-007-9167-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:45:57Z","timestamp":1559238357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-007-9167-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,18]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["9167"],"URL":"https:\/\/doi.org\/10.1007\/s10689-007-9167-3","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,18]]}}}